NFIB and adrenal cortex carcinoma: Persson et al. were the first group to report recurrent MYB–NFIB fusion as a key oncogenic event in the pathogenesis of ACC, using cytogenetic and karyotype analyses of head, neck and breast ACC, as well as by reverse transcriptase polymerase chain reaction (RT-PCR).